Results 51 to 60 of about 20,687 (197)

Mesenchymal Chondrosarcoma Presenting as Atypical Brown–Sequard Syndrome

Annals of the Child Neurology Society, EarlyView.
Naman D. Shah, Adam Z. Kalawi, Rachel Pearson, Ali Nael, John R. Crawford   +4 more
wiley   +1 more source

NFE2L2‐mutated urothelial carcinomas frequently show concomitant myxoid and squamous features and have high PD‐L1 expression

Histopathology, EarlyView.
Aims NFE2L2 encodes the transcription factor, NRF2, which is a regulator of cellular oxidative stress responses and metabolic homeostasis. NFE2L2 alterations are implicated in multiple cancers, with significant study in thoracic oncology, with an adverse prognosis, aggressive behaviour, metabolic reprogramming and diminished responses to chemotherapy ...
Dane Wuori, Alexander Guzzetta, Melissa Y. Tjota, Peng Wang, Tatjana Antic, Jung Woo Kwon   +5 more
wiley   +1 more source

Clinicopathology of chondrosarcoma.

Acta medica Okayama, 1996
We conducted a clinicopathological analysis of chondrosarcomas in 17 patients treated in our institute. The 5- and 10-year overall survival rates of the patients were 72.3% and 61.9%, respectively. The significant prognostic factors were size and histologic grade of the tumor.
Uchida, Yoichiro, Kawai, Akira, Taguchi, Kohji, Yokoi, Tadashi, Pu, Jian, Inoue, Hajime   +5 more
openaire   +3 more sources

Identification of ZNF704 as a Novel Oncogene and an Independent Prognostic Marker in Chondrosarcoma

Cancer Management and Research, 2021
Changbao Chen,1 Hua Zhou,2 Xiaolin Zhang,1 Zhongjun Liu,2 Xinlong Ma1 1Department of Spinal Surgery, Tianjin Hospital, Tianjin, 300211, People’s Republic of China; 2Department of Orthopaedic Surgery, Peking University Third Hospital, Beijing ...
Chen C, Zhou H, Zhang X, Liu Z, Ma X
doaj  

Advanced Uterine Carcinosarcoma With Fatal Suspected Pulmonary Embolism in a Resource‐Limited Setting: A Rare Case Report

Clinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Uterine carcinosarcoma (UCS), also known as malignant mixed Müllerian tumor (MMMT), is a biphasic neoplasm characterized by the presence of carcinomatous (epithelial) and sarcomatous (stromal tissue) elements. It frequently presents at an advanced stage and can mimic primary ovarian carcinoma on clinical and radiological evaluation ...
John Lugata, Onesmo Mrosso, Tecla Lyamuya, Jasmine E. Arrington, Elizabeth Skinner, Bariki Mchome, Eusebious Maro, Alex Mremi   +7 more
wiley   +1 more source

Chondrosarcoma of the Proximal Phalanx of the Fourth Digit: A Rare Location

Case Reports in Oncology, 2012
Introduction: Cartilaginous tumors involving the small bones of the hands and feet are usually benign such as enchondroma, chondromyxoid fibroma and chondroblastoma.
Thivi Vasilakaki, Aikaterini Tsavari, Evangelia Skafida, Kalliroi Koulia, Despina Myoteri, Xanthipi Grammatoglou, Alexandra Zisi, Nikolaos Firfiris, Kassiani Manoloudaki   +8 more
doaj   +1 more source

A living biobank of sarcoma patient‐derived cell cultures reveals multi‐omic and functional insights that capture disease heterogeneity

Clinical and Translational Medicine, Volume 16, Issue 7, July 2026.
Preclinical models for sarcoma that preserve tumour biology are urgently needed to advance mechanistic understanding and functional precision oncology. 29 early‐passage patient‐derived sarcoma cell (PDC) cultures from 19 patients, representing 11 sarcoma subtypes were established and extensively characterized.
Stefanie Gijsels, Suzanne Fischer, David Creytens, Sándor Dedeyne, Felix De Vuyst, Cláudio Pinheiro, Fleur Cordier, Sarah‐Lee Bekaert, Nadine Van Roy, Kaat Durinck, Jarne Pauwels, Kris Gevaert, Pieter Mestdagh, Jo Vandesompele, Pekka Rappu, Jyrki Heino, An Hendrix, Gabrielle H. van Ramshorst, Gwen Sys, Olivier De Wever   +19 more
wiley   +1 more source

Description of the immune microenvironment of chondrosarcoma and contribution to progression

OncoImmunology, 2017
Chondrosarcoma (CHS) is a rare bone malignancy characterized by its resistance to conventional systemic and radiation therapies. Whether immunotherapy targeting immune checkpoints may be active in these tumors remains unknown.
François A. Simard, Iseulys Richert, Alexandra Vandermoeten, Anne-Valérie Decouvelaere, Jean-Philippe Michot, Christophe Caux, Jean-Yves Blay, Aurélie Dutour   +7 more
doaj   +1 more source

Rare Clear Cell Chondrosarcoma Detected on PET/CT in a Patient With Von Hippel–Lindau Disease

iRADIOLOGY, EarlyView.
Kun Tang, Ling Wang
wiley   +1 more source

Skull Base Surgery in the Pediatric Population—The 2nd International Collaborative Study (1995–2015)

Head &Neck, Volume 48, Issue 7, Page 1742-1754, July 2026.
ABSTRACT Background The current study presents the efforts of a global collaborative group to review the management and outcomes of malignant tumors of the skull base in the pediatric population worldwide. Patients and Methods A total of 28 institutions contributed data on 3061 patients. From this, there were 64 pediatric patients (2.1%).
Dan M. Fliss, Omer J. Ungar, Helena Levyn, Cristina Valero, Dauren Adilbay, Alana Eagan, Junting Zheng, Mithat Gonen, Marc A. Cohen, Snehal Patel, Ian Ganly, Prathamesh Pai, Paolo Castelnuovo, Fang Ju Gao, Cesare Piazza, Piero Nicolai, Benedict J. Panizza, James Bowman, Catherine Barnett, Luiz P. Kowalski, Ronaldo N. Toledo, John DeAlmeida, Ian Witterick, Philippe Herman, Walter Fontanella, Gregorio Sanchez Aniceto, Sefik Hosal, Serdar Ozer, Subramania Iyer, Richard Harvey, C. Rene Leemans, Jan‑Jaap Hendrickx, Marcelo Figari, Luis Boccalatte, Ichi Nibu, Peter Clarke, Catherine Rennie, Yiming Zhu, Claudio Cernea, Sergio Goncalves, Rodney Schlosser, Fernando Dias, Zoukaa Sargi, Shahzada Ahmed, Wojciech Golusinski, Se Heon Kim, Shirley Y. Su, Shaan M. Raza, Franco DeMonte, Ehab Hanna, Jatin P. Shah   +50 more
wiley   +1 more source